NCT03459222 2025-04-02An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have SpreadBristol-Myers SquibbPhase 1/2 Completed229 enrolled
NCT03203876 2022-03-10A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid TumorsBristol-Myers SquibbPhase 1 Completed10 enrolled